Scott Layne, M.D.
Dr. Scott Layne is a physician and scientist who is known for cross-disciplinary work involving biology, virology, applied physics, and policy-related issues. He graduated from Case Western Reserve University School of Medicine and engaged in residencies at the University of California at San Francisco, Loma Linda University, and the UCLA Medical Center, where he specialized in Anesthesiology, Psychiatry, and Internal Medicine. The physician is fellowship-trained in Infectious Disease by the UCLA Medical Center. Dr. Scott Layne is the author of numerous publications and a professional member of the Infectious Diseases Society of America, the American College of Physicians, and the Infectious Disease Association of California. He is a Professor at the Saint John's Cancer Institute, Professor Emeritus at the UCLA School of Public Health, and a former Staff Member at the Los Alamos National Laboratory and Lawrence Livermore National Laboratory.
From 2005 to 2010, in a joint venture with UCLA and LANL, the physician designed and oversaw the creation of a high-throughput laboratory facility for analyzing numerous infectious disease samples. Its goal was to enable worldwide situational awareness of outbreaks and pandemics. During that time, he served as Principal Investigator of the NIAID/NIH Center of Excellence for Rapid Influenza Surveillance and Response, which conducted national and international studies of animal and human-derived influenza strains. In 1988, Dr. Scott Layne organized the workshop "A National Effort to Model AIDS Epidemiology" for the White House Office of Science and Technology Policy. In 1999, he organized the meeting "Automation in Thread Reduction and Infectious Diseases Research" under the auspices of the Institute of Medicine and National Academy of Engineering.
From 2008 to 2010, the physician served as a member of the National Biosurveillance Advisory Subcommittee as authorized by Homeland Security Presidential Directive-21. Dr. Scott Layne has over 50 publications, including two books and six patents. In March 2020, he authored a Science Translational Medicine Editorial on establishing effective pandemic responses that remain relevant to this day. In July 2021, the physician authored a second Science Translational Medicine Editorial on the need for a new Global COVID-19 Program of surveillance that outlines a framework for creating it. Dr. Scott Layne has cared for hundreds of patients who were hospitalized for acute SARS-CoV-2 infections and life-threatening COVID-19. He has over 40 years of professional experience and before practicing in California, he had a medical license for New Mexico.
Conditions Dr. Scott Layne Treats at Cedars-Sinai Marina del Rey Hospital
- Blue Cross / Blue Shield
Education & Training
Case Western Reserve University
Psychiatry, Loma Linda University
Internal Medicine, UCLA Department of Medicine
(Adult) Infectious Diseases, UCLA Department of Medicine
Memberships & Affiliations
Publications & Media
Diagnosis of influenza virus: Coming to grips with the molecular era.
Jeffery K. Taubenberger, Scott P. Layne
Modelling an outbreak of an emerging pathogen.
Emily Kajita, Justin T Okano, Erin N. Bodine, Scott P. Layne, Sally Blower
Risk behavior-based model of the cubic growth of acquired immunodeficiency syndrome in the United States.
Stirling A. Colgate, E.A. Stanley, James M. Hyman, Scott P. Layne, C Qualls
Pandemic influenza: an inconvenient mutation.
Scott P. Layne, Arnold S. Monto, Jeffery K. Taubenberger
Human influenza surveillance: the demand to expand.
Scott P. Layne
High-throughput laboratories for Homeland and National Security.
Scott P. Layne, Tony J. Beugelsdijk